The Fate of Aortic Valve After SAS Surgery in Children
Completed
- Conditions
- Subaortic StenosisCongenital Heart DiseaseAortic Regurgitation
- Registration Number
- NCT06751368
- Lead Sponsor
- Chinese Academy of Medical Sciences, Fuwai Hospital
- Brief Summary
Aortic valve regurgitation (AR) is a common complication following surgery for subaortic stenosis (SAS), yet the long-term outcomes and risk factors for postoperative significant AR (SAR) remain poorly understood. This study aims to investigate the incidence and risk factors of SAR in SAS patients and evaluate the long-term postoperative outcomes.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 232
Inclusion Criteria
- Age from 0-18
- Clinical diagnosis of subaortic stenosis and underwent surgery
Exclusion Criteria
- Diagnosed with hypertrophic cardiomyopathy
- Underwent concomitant previous surgical repair for aortic valve or SAS
- Follow-up time less than 1 year or lack of detailed information.
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Rate of Postoperative significant AR (SAR) Through study completion, an average of 4 year
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular pathways contribute to aortic valve degeneration after subaortic stenosis repair in pediatric patients?
How do surgical techniques for subaortic stenosis impact long-term aortic valve function in congenital heart disease?
Which biomarkers predict significant aortic regurgitation risk post-SAS surgery in congenital heart disease patients?
What are the long-term re-intervention rates for aortic valve replacement after SAS repair in pediatric cohorts?
Are pharmacological agents targeting extracellular matrix remodeling effective in preventing post-SAS aortic regurgitation?
Trial Locations
- Locations (1)
Fuwai Hospital
🇨🇳Beijing, Beijing, China
Fuwai Hospital🇨🇳Beijing, Beijing, China